1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Chris Seaman
Our people

Dr Chris Seaman

Research Officer

Working groups

chris.seaman@burnet.edu.au
Dr Chris Seaman

Background

Chris completed his PhD at the Burnet Institute in 2023, with his thesis titled “Using mathematical models to guide elimination of hepatitis B as a public health”.

Chris has experience working with global stakeholders including PATH and the World Health Organization (WHO). This research has included investigation of new approaches, including the controlled temperature chain (CTC) or microarray patches (MAPs), to overcome barriers associated with delivery of the hepatitis B birth dose vaccine in low-and middle-income countries.

Chris’ current research focus is the on-going development and implementation of a dynamic hepatitis B mathematical model (designed as part of his PhD), which will be used within the 2022-2027 Vaccine Impact Modelling Consortium (VIMC).   

Qualifications

  • 2023: PhD, Monash University
  • 2017: Master of Science (Epidemiology), University of Melbourne
  • 2014: Bachelor of Biomedical Science (Honours), RMIT University

Positions

  • 2023-ongoing: Research Officer, Modelling and Biostatistics
  • 2020-2022: Research Assistant, Modelling and Biostatistics

Burnet publications

View 8 more
27 Jul 2023

A global investment case for hepatitis B elimination: a modelling study

˜The œLancet. Gastroenterology & hepatology

Phillip Luong, Chris Seaman, Yinzong Xiao, Romesh Abeysuriya, Jess Howell, Margaret Hellard, Nick Scott, Chris Seaman, Phillip Luong, Yinzong Xiao

27 Jul 2023

A global investment case for hepatitis B elimination: a modelling study

˜The œLancet. Gastroenterology & hepatology

Phillip Luong, Chris Seaman, Yinzong Xiao, Romesh Abeysuriya, Jess Howell, Margaret Hellard, Nick Scott, Chris Seaman, Phillip Luong, Yinzong Xiao

01 May 2023

Pathway to global elimination of hepatitis B: HBV cure is just the first step

Hepatology

Yinzong Xiao, Jessica Howell, Chris Seaman, Jack Wallace, Nick Scott, Karine Lacombe, Olufunmilayo Lesi, Rosmawati Mohamed, Marcelo José Barbosa Silva, Margaret Hellard

Open access

Current projects

Hepatitis B modelling
Open to students

Hepatitis B modelling

We use mathematical and economic models to inform global efforts to achieving the elimination of hepatitis B as a public health threat.

Past projects

The elimination of hepatitis C as a global public health threat

The elimination of hepatitis C as a global public health threat

This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

News and features

Burnet modelling reveals global economic burden of hepatitis B

Burnet modelling reveals global economic burden of hepatitis B

New Burnet Institute modelling has revealed the significant cost of hepatitis B deaths globally and emphasises the under appreciated economic burden of hepatitis B.

On this page